NCT01327456

Brief Summary

Purpose: To determine the role health literacy plays in the care continuum for Chronic Obstructive Pulmonary Disease (COPD) and the effect of a self-management intervention on inhaler technique use, time spent on self-management, and knowledge for COPD patients with low literacy. Participants: The investigators will recruit patients from the University of North Carolina at Chapel Hill Ambulatory Care Center (ACC) who have a diagnosis of COPD. Procedures (methods): Potential subjects with COPD will be identified through pharmacy claims data, clinic billing data and the electronic medical record. Eligibility will be prescreened by a research assistant (RA) using the electronic medical record prior to approaching potential subjects for consent. For the first part of the study, consenting subjects will complete a baseline health literacy assessment, a questionnaire, an inhaler technique assessment, and a diary of time spent in self-management activities. Pulmonary function tests (PFT) will be performed on all participants for whom PFTs have not been conducted within the previous 12 months. The questionnaire will include measures of COPD-related knowledge, self-management techniques, quality of care, access, quality of life, costs, healthcare utilization, exacerbations, and basic demographic information. The inhaler technique assessment will be administered by the research assistant using a pre-established protocol. The research assistant will abstract additional data from the medical record to assess the quality of care based on adherence to recommended COPD care guidelines. For the second part of the study, participants will be randomized to control and intervention arms. The self-management intervention will be an interactive experience, delivered by a trained research assistant, targeting self-management skills (inhaler use, using an action plan, etc), smoking cessation, and exercise/pulmonary rehabilitation. Those randomized to the control group will receive usual care. All participants will return 2-4 weeks after the intervention for a follow-up assessment of inhaler technique, COPD-related knowledge, and time spent in self-management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Jan 2008

Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 1, 2011

Completed
Last Updated

April 1, 2011

Status Verified

March 1, 2011

Enrollment Period

11 months

First QC Date

March 29, 2011

Last Update Submit

March 31, 2011

Conditions

Keywords

health literacyself-managementinhaler technique

Outcome Measures

Primary Outcomes (1)

  • change in Inhaler use technique scores from baseline to follow-up

    The inhaler technique assessment will be conducted by using a pre-established protocol developed to cover the major types of inhalers used by the COPD population. General principles included in the assessment include correct preparation, administration, and if appropriate re-administration of a dose. The assessment will be scored as number of steps completed correctly out of total number of steps assessed.

    baseline and at 2-4 weeks later

Secondary Outcomes (3)

  • time spent in self-management activities

    2-4 weeks

  • change in COPD-related knowledge from baseline to follow-up

    baseline and 2-4 week follow-up

  • change in smoking status from baseline to follow-up

    baseline and 2-4 week follow-up

Study Arms (2)

Self-Management Intervention

EXPERIMENTAL

participants who receive the one-on-one self-management intervention

Behavioral: Self-Management Intervention

Usual Care

NO INTERVENTION

group receives no additional education or intervention then they would as usual care of their COPD

Interventions

patients will participate in a 1-on-1 interactive intervention, delivered by a trained research assistant targeting self-management skills (e.g. inhaler use, use of an action plan), smoking cessation, and exercise/pulmonary rehabilitation. All participants will return 2-4 weeks after the intervention for a follow-up assessment of inhaler technique use, COPD-related knowledge, and time spent in self-management.

Self-Management Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • are age 18 years or older and,
  • have been diagnosed with COPD
  • are active patients in the General Internal Medicine or Pulmonary Clinics at the Ambulatory Care Center
  • are being treated with inhaled medication for their COPD

You may not qualify if:

  • non-English speaking (intervention will be available in English only)
  • participants unable to complete the study (either with or without assistance)
  • patients who are currently experiencing an exacerbation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina Hospitals Ambulatory Care Center

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Daniel Jonas, MD

    University of North Carolina

    PRINCIPAL INVESTIGATOR
  • Katie Kiser, Pharm.D.

    University of North Carolina

    PRINCIPAL INVESTIGATOR
  • Darren Dewalt, MD

    University of North Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 29, 2011

First Posted

April 1, 2011

Study Start

January 1, 2008

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

April 1, 2011

Record last verified: 2011-03

Locations